(redirected from Cannabigerol)
Also found in: Wikipedia.
Category filter:
CBGCar Buyers Guide
CBGCanadian Brigade Group
CBGCommercial Banking Group
CBGCorticosteroid Binding Globulin
CBGCommunity Bank Group (various organizations)
CBGConsulting Business Group Inc.
CBGComics Buyer's Guide
CBGChicago Botanic Garden
CBGComic Book Guy (The Simpsons)
CBGCigar Box Guitar
CBGCompagnie des Bauxites de Guinée (French: Bauxite Company of Guinea; Guinea)
CBGCinema Buying Group
CBGCapillary Blood Glucose
CBGCharities Buying Group
CBGCharlie Boy Gang (band)
CBGCarrier Battle Group
CBGCleveland Botanical Garden
CBGCenter for Business and Government
CBGCapillary Blood Gas
CBGCampaign Builders' Guild (gaming guild)
CBGChina Business Guide (China)
CBGComic Book Galaxy (website)
CBGClean Burning Gasoline
CBGComic Book Geek
CBGCrazy Boys Generation (band)
CBGCharlier-Brabo Group (Belgium)
CBGCambridge, England, United Kingdom - Cambridge (Airport Code)
CBGConcrete Box Girder (construction)
CBGCorporate Business Group
CBGCoronary Bypass Graft
CBGCommunity Block Grant
CBGCaught Being Good (education)
CBGCompagnie des Bois du Gabon (French: Gabon Timber Company; Gabon)
CBGCollins Bird Guide (UK)
CBGCarlson Barbee & Gibson (California civil engineering firm)
CBGCenter for Biomedicine and Genetics (Duarte, CA)
CBGChemometrics and Bioinformatics Group (Norwegian University of Science and Technology)
CBGCreepy Bald Guy (Fringe TV show)
CBGChip the Beer Guy
CBGChaotic Blader Games
CBGCouelle, Bretones, Garcia (French architecture firm)
CBGComputer Buyer's Guide
CBGCarlos Britt Gisbert (Konsult & Information AB, Sundbybert, Sweden)
CBGCathelineau, Bagouet, Guevenoux (French law firm)
CBGCatapult Brands Group (Miami Beach, FL)
CBGCardiac Bypass Graft (surgical procedure)
CBGCarolina Building Group (Charlotte, NC and Lancaster, SC)
CBGCommercial Buyers Guide
CBGClub de Billard de Grosbliederstroff (French: Grosbliederstroff Billiard Club; Grosbliederstroff, France)
CBGComptoir du Bureau Ghielmini, SA (French: Office Desk Ghielmini, SA; Switzerland)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
Our Quantification process then identifies and measures the amount of total Cannabidiol (CBDA + CBD), Tetrahydrocannabinol (A9THCA + A9THC + A8THC), Cannabinol (CBN), Cannabichromene (CBC) and Cannabigerol (CBGA +CBG).
Romano et al., "Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid," Carcinogenesis, vol.
Cayman Chemical's Phytocannabinoid Mixture 10 (CRM) is a quantitative, multi-analyte mixture for use as an analytical standard in the simultaneous detection of the 10 most prevalent phytocannabinoids found in cannabis plants: cannabidivarin (CBDV), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabidiol (CBD), cannabinol (CBN), tetrahydrocannabinolic acid A (THCA-A), [DELTA]9-tetrahydrocannabinol ([DELTA]9-THC), [DELTA]8-tetrahydrocannabinol ([DELTA]8-THC), and ([+ or -])-cannabichromene (CBC).
Among the other cannabinoids, the most studied ones are dronabinol (DBN) and nabilone, followed by cannabinol (CBN), cannabidiol (CBD), which seems to possess some anti-inflammatory, analgesic (Hohmann & Suplita, 2006; Rea, Roche & Finn, 2007; Jhaveri et al, 2008), anti-schemic (Lamontagne et al, 2006), antipsychotic (Leweke, Koethe & Gerth, 2005), ansiolitic (Crippa et al, 2011), and anti-epileptic effects (Mortati, Dworetzky & Devinsky, 2007); and finally, cannabigerol (CBG) and cannabicromeno (CBC) (Barceloux, 2012), which possess some properties which have been studied mainly in preclinical or animal models.
Chemical constituents: Tetrahydrocannabinol, cannabidiol, cannabichromene, cannabicitran, cannabicyclol, cannabigerol, cannabinodiol, and cannabitetrol (Haq and Hussain, 1993; Kaushik and Dhiman, 1999; Prajapati et al., 2003; Khare, 2007).
In this case, colitis was induced by intracolonic administration of dinitrobenzene sulfonic acid (DNBS), and mice were treated using a nonpsychotropic cannabinoid, known as cannabigerol [50].
Other minor cannabinoids such as cannabigerol (CBG), [[DELTA].sup.9]-tetrahydrocannabivarin (THCV), and its metabolite 11-nor-9-carboxy-THCV (THCVCOOH) may also serve as recent use markers; however, their blood pharmacokinetics have not been characterized, with previous identification only in cannabis smokers' urine (11-13).
All majority cannabinoids, cannabidiol (7), cannabichromene (8), cannabigerol (9), [[DELTA].sup.9]-tetrahydrocannabinol (1) and cannabinol (10) (Figure 3), showed potent activity against a variety of methicillin-resistant S.
Other medically- relevant and well characterized cannabinoids include; [DELTA]-9-tetrahydrocannabivarin (THCV), cannabidiol (CBD), cannabigerol (CBG), cannabichromene (CBC) cannabinol (CBN) and cannabidivarin (CBDV); with THC, CBD and CBN being the most abundant phytocannabinoids (Table 1).
Most states usually only require reporting for tetrahydrocannabinol (THC) and cannabidiol (CBD) and their associated acids, tetrahydrocannabinolic acid and cannabidiolic acid, but some labs choose to quantify other cannabinoids, such as cannabigerol (CBG) and cannabichromene (CBC).